# FDA Inspection 1103220 - Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - September 27, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/snyder-mark-drugs-roselle-inc-dba-mark-drugs-pharmacy/8b5d395e-cc9f-4e05-afd3-225c4c7ea673/
Source feed: FDA_Inspections

> FDA Inspection 1103220 for Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on September 27, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103220
- Company Name: Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy
- Inspection Date: 2019-09-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1015476 - 2017-05-22](https://www.globalkeysolutions.net/api/records/fda_inspections/snyder-mark-drugs-roselle-inc-dba-mark-drugs-pharmacy/2331290f-5f8e-4072-9e69-ab70fefd01fc/)

Company: https://www.globalkeysolutions.net/companies/snyder-mark-drugs-roselle-inc-dba-mark-drugs-pharmacy/74c7ab2d-4c4c-422e-a806-eff558e5304f

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c